Two Blood Monocytic Biomarkers (CCL15 and p21) Combined with the Mini-Mental State Examination Discriminate Alzheimer’s Disease Patients from Healthy Subjects

Two Blood Monocytic Biomarkers (CCL15 and p21) Combined with the Mini-Mental State Examination Discriminate Alzheimer’s Disease Patients from Healthy Subjects

Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder. In AD, monocytes migrate across the blood-brain barrier and differentiate into microglia, are linked to inflammatory responses and display age-dependent decreases in telomere lengths. Methods: Six monocyte-specific che...

Full description

Bibliographic Details
Main Authors: Tanja Hochstrasser, Josef Marksteiner, Michaela Defrancesco, Eberhard A. Deisenhammer, Georg Kemmler, Christian Humpel
Format: Article
Language:English
Published: Karger Publishers 2011-10-01
Series:Dementia and Geriatric Cognitive Disorders Extra
Subjects:
Alzheimer’s disease
Blood parameters
Chemokines
Dementia markers
Differential diagnosis, Alzheimer’s disease
Monocytes
Online Access:http://www.karger.com/Article/FullText/330468

Internet

http://www.karger.com/Article/FullText/330468

Similar Items